Teva share price doubles since Schultz became CEO

Kare Schultz photo: PR
Kare Schultz photo: PR

Allergan has taken advantage of the higher price to sell Teva shares for $124 million.

The positive momentum in Teva Pharmaceutical Industries Ltd.'s (NYSE: TEVA; TASE: TEVA) share price continued late last week in New York, even after what might seem to be bad news for the company. The downgrading of Teva's bonds to junk bond by the Moody's credit rating agency and the report of another sale of Teva shares by Allergan did not affect the positive sentiment towards the share, whose price rose 1.5% on Friday, after leaping 8.5% on Thursday.

Teva's current share price is $22.10, reflecting a $22.4 billion market cap. Since hitting its lowest point in early November on the day after Kare Schultz became Teva's new CEO, Teva's share price has almost doubled.

From a broader perspective, the company's share price is still 28.6% lower than it was in early August, when Teva's second quarter reports were published. Those reports included a huge write-down for good will and a downward revision of the company's guidance for the year. Allergan has taken advantage of the recent surge in Teva's share price to sell some of its shares in Teva, after become the largest shareholder in Teva with a 9.9% stake when Teva acquired Actavis, Allergan's generic division in a cash-and-shares deal in 2016.

According to a report to the US Securities and Exchange Commission (SEC) late last week, Allergan sold 6.55 million Teva shares over the past month at prices varying from $18.10 to $20.10 for a total of $124 million. Allergan thereby reduced its stake in Teva to 6.8%, with a current market value of $1.5 billion. When Allergan first acquired its Teva shares in August 2016, they were worth $5.3 billion, but the downward spiral in Teva's share price forced Allergan to recognize a $3.3 billion decrease in the value of its Teva shares in preceding quarters. Two months ago, Allergan reached an agreement with the JP Morgan bank, in which it encumbered 25 million Teva shares to secure a loan from the bank to Allergan.

Published by Globes [online], Israel Business News - www.globes-online.com - on January 14, 2018

© Copyright of Globes Publisher Itonut (1983) Ltd. 2018

Kare Schultz photo: PR
Kare Schultz photo: PR
Israeli startup gems 2022 Globes names Finout "Most Promising Startup of 2025"

Cloud cost management solutions company Finout tops the list of Israeli startups most likely to succeed named by 80 local and foreign funds.

Mobileye CEO Amnon Shashua credit: Heinz Troll European Patent Office Mobileye posts strong Q1, reaffirms guidance despite tariffs

The Israeli advanced driving assistance systems company beat analysts' expectations on revenue and met expectations on non-GAAP net profit.

Xtend drones credit: Xtend Sentrycs teams with Xtend to strengthen drone security

The aim of the all-Israeli collaboration is to create a synergy of proven capabilities in a world where drones have become a major threat.

Intel Haifa  credit: Shutterstock Intel layoffs in Israel will benefit rivals

Industry experts agree that Intel staff dismissed in Israel will have no trouble finding work at rivals like Nvidia, as happened during last year's layoffs.

Ministry of Finance Jerusalem credit: Shutterstock Treasury sees Trump's tariffs cutting Israel's GDP growth

Amid the uncertainty that still surrounds the level of tariffs that would ultimately be imposed on Israeli goods, the annual damage to growth is estimated by the Finance Ministry at less than 0.5% of GDP.

French President Emmanuel Macron at the Paris Air Show in 2023 credit: Reuters Israel to scale down Paris Air Show presence

Due to President Emmanuel Macron's antagonism, Israel is reducing its presence at the exhibition, Ministry of Defense International Defense Cooperation Directorate (SIBAT) head Yair Kulas tells "Globes."

Jerusalem court cmplex credit: Zarhy Architects Tenders issued for two huge Jerusalem construction projects

The PFI tenders for the Gan Hotzvim tech campus and the courts complex include grants of NIS 1.7 billion for the winning bidders.

Israel Innovation Authority CEO Dror Bin Innovation Authority chief: Israel top for deep tech investment

Dror Bin told the Globes TECH IL conference that deep tech is the next wave for global tech and the rate of investment in Israel is the world's highest.

Gil Shwed and Nadav Zafrir credit: Menash Cohen With new CEO Check Point beats analysts in Q1

Revenue rose 6.5% and GAAP net profit rose 5% in Nadav Zafrir's first full quarter at the helm.

Tel Aviv light rail credit: Yossi Cohen Rishon Lezion to finance Red Line light rail extension

The Rishon Lezion Municipality will pay for part of the extension by marketing land above the planned underground depot.

Intel Haifa development center credit: Shutterstock Intel to cut 20% of workforce - report

"Bloomberg" reports that new CEO Lip-Bu Tan will announce the layoffs this week.

Healthee team credit: Healthee PR AI healthcare costs management co Healthee raises $50m

Healthee’s benefits and care navigation platform empowers employees and employers to make the most of their health benefits.

Former Shufersal CEO Itzik Abercohen credit: Eyal Izhar Competition Authority summons former Shufersal CEO to hearing

According to the indictment, Shufersal and Itzik Abercohen allegedly made public statements through which he attempted to reach arrangements to raise prices.

Reco founders Ofer Klein, Gal Nakash, and Tal Shapira credit: Elegant Photographics Israeli SaaS security co Reco raises $25m

The Tel Aviv-based company has developed a comprehensive application discovery engine capable of identifying and classifying over 50,000 applications, and providing visibility into an organization’s SaaS ecosystem.

Tel Aviv Stock Exchange credit: Tali Bogdanovsky TASE outperforms global markets in 2025

Boosted by the strong results of Israel's banks, the Tel Aviv Stock Exchange has demonstrated impressive resilience to domestic and foreign upheavals.

Metro credit: Bar Lavi Can Hyundai fill Metro vacuum created by China's exclusion?

The South Korean giant is reportedly eager to enter Israel's infrastructure sector but may not have the resources to dig the Metro tunnels.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018